Marshall Wace’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.4M Buy
4,138,176
+2,981,240
+258% +$15.1M 0.02% 714
2025
Q4
$4.93M Buy
1,156,936
+51,943
+5% +$197K ﹤0.01% 1167
2025
Q3
$3.52M Sell
1,104,993
-1,248,129
-53% -$2.81M ﹤0.01% 1348
2025
Q2
$5.34M Buy
2,353,122
+2,267,583
+2,651% +$3.66M 0.01% 1108
2025
Q1
$54.7K Buy
+85,539
New +$66.3K ﹤0.01% 2531
2024
Q2
Sell
-52,289
Closed -$114K 2627
2024
Q1
$114K Sell
52,289
-310,987
-86% -$574K ﹤0.01% 2297
2023
Q4
$563K Sell
363,276
-14,317
-4% -$18.8K ﹤0.01% 1680
2023
Q3
$487K Sell
377,593
-296,908
-44% -$467K ﹤0.01% 1735
2023
Q2
$1.16M Sell
674,501
-55,437
-8% -$92K ﹤0.01% 1649
2023
Q1
$1.1M Buy
+729,938
New +$1.65M ﹤0.01% 1762
2022
Q4
Sell
-40,021
Closed -$58K 3023
2022
Q3
$58K Sell
40,021
-24,123
-38% -$37.1K ﹤0.01% 3232
2022
Q2
$118K Buy
64,144
+48,878
+320% +$93.6K ﹤0.01% 3254
2022
Q1
$40K Buy
+15,266
New +$58.6K ﹤0.01% 3253
2020
Q2
Sell
-117,393
Closed -$900K 1615
2020
Q1
$900K Sell
117,393
-284,033
-71% -$1.98M 0.01% 824
2019
Q4
$3.34M Buy
401,426
+393,401
+4,902% +$2.65M 0.02% 662
2019
Q3
$59K Buy
+8,025
New +$79.2K ﹤0.01% 1470
2019
Q1
Sell
-51,876
Closed -$783K 1772
2018
Q4
$783K Sell
51,876
-28,532
-35% -$423K 0.01% 977
2018
Q3
$1.49M Buy
+80,408
New +$1.83M 0.01% 736
2018
Q2
Sell
-12,100
Closed -$344K 726
2018
Q1
$344K Buy
+12,100
New +$345K 0.01% 440

Other funds holding CTMX